Oscar Puig

Oscar Puig serves as the Head of Translational Medicine & Diagnostics at Nucleai, an AI-driven company specializing in pathology data analysis for biomarker development. Additionally, Oscar is an Adjunct Professor of Artificial Intelligence at Stevens Institute of Technology. Prior experience includes leading clinical biomarkers and diagnostics at BeiGene, directing translational medicine at Eli Lilly, and holding significant positions at Bristol Myers Squibb, Phosphorus, Roche, Merck, and the University of Helsinki. Oscar's academic credentials include a PhD in Molecular Biology and an MSc in Biochemistry from the University of Valencia.